Annual Net Income:
-$3.56B+$1.15B(+24.46%)Summary
- As of April 3, 2025, MRNA annual net profit is -$3.56 billion, with the most recent change of +$1.15 billion (+24.46%) on December 31, 2024.
- During the last 3 years, MRNA annual net income has fallen by -$15.76 billion (-129.18%).
- MRNA annual net income is now -129.18% below its all-time high of $12.20 billion, reached on December 31, 2021.
Performance
MRNA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income:
-$1.12B-$1.13B(-8715.38%)Summary
- As of April 3, 2025, MRNA quarterly net profit is -$1.12 billion, with the most recent change of -$1.13 billion (-8715.38%) on December 31, 2024.
- Over the past year, MRNA quarterly net income has dropped by -$1.34 billion (-616.13%).
- MRNA quarterly net income is now -123.01% below its all-time high of $4.87 billion, reached on December 31, 2021.
Performance
MRNA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income:
-$3.56B-$1.34B(-60.12%)Summary
- As of April 3, 2025, MRNA TTM net profit is -$3.56 billion, with the most recent change of -$1.34 billion (-60.12%) on December 31, 2024.
- Over the past year, MRNA TTM net income has increased by +$1.15 billion (+24.46%).
- MRNA TTM net income is now -124.33% below its all-time high of $14.64 billion, reached on March 31, 2022.
Performance
MRNA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MRNA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | -616.1% | +24.5% |
| 3 y3 years | -129.2% | -616.1% | +24.5% |
| 5 y5 years | -592.8% | -616.1% | +24.5% |
MRNA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.2% | +24.5% | -130.6% | +69.2% | -124.3% | +40.3% |
| 5 y | 5-year | -129.2% | +24.5% | -123.0% | +69.2% | -124.3% | +40.3% |
| alltime | all time | -129.2% | +24.5% | -123.0% | +69.2% | -124.3% | +40.3% |
Moderna Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$3.56B(-24.5%) | -$1.12B(-8715.4%) | -$3.56B(+60.1%) |
| Sep 2024 | - | $13.00M(-101.0%) | -$2.22B(-62.1%) |
| Jun 2024 | - | -$1.28B(+8.9%) | -$5.87B(-1.7%) |
| Mar 2024 | - | -$1.18B(-641.5%) | -$5.97B(+26.6%) |
| Dec 2023 | -$4.71B(-156.4%) | $217.00M(-106.0%) | -$4.71B(+36.0%) |
| Sep 2023 | - | -$3.63B(+163.0%) | -$3.47B(-387.2%) |
| Jun 2023 | - | -$1.38B(-1846.8%) | $1.21B(-74.8%) |
| Mar 2023 | - | $79.00M(-94.6%) | $4.78B(-42.8%) |
| Dec 2022 | $8.36B(-31.5%) | $1.47B(+40.5%) | $8.36B(-28.9%) |
| Sep 2022 | - | $1.04B(-52.5%) | $11.77B(-16.3%) |
| Jun 2022 | - | $2.20B(-39.9%) | $14.05B(-4.0%) |
| Mar 2022 | - | $3.66B(-24.9%) | $14.64B(+20.0%) |
| Dec 2021 | $12.20B(-1733.5%) | $4.87B(+46.1%) | $12.20B(+72.8%) |
| Sep 2021 | - | $3.33B(+19.9%) | $7.06B(+102.0%) |
| Jun 2021 | - | $2.78B(+127.7%) | $3.50B(+484.4%) |
| Mar 2021 | - | $1.22B(-547.3%) | $598.00M(-180.1%) |
| Dec 2020 | -$747.00M(+45.3%) | -$273.00M(+17.2%) | -$747.00M(+25.1%) |
| Sep 2020 | - | -$233.00M(+99.1%) | -$597.27M(+22.5%) |
| Jun 2020 | - | -$117.00M(-5.6%) | -$487.48M(-3.5%) |
| Mar 2020 | - | -$124.00M(+0.6%) | -$505.42M(-1.7%) |
| Dec 2019 | -$514.00M(+33.6%) | -$123.27M(+0.0%) | -$514.00M(-3.4%) |
| Sep 2019 | - | -$123.22M(-8.7%) | -$532.16M(+8.8%) |
| Jun 2019 | - | -$134.94M(+1.8%) | -$489.27M(+10.0%) |
| Mar 2019 | - | -$132.58M(-6.3%) | -$444.93M(+15.6%) |
| Dec 2018 | -$384.73M(+50.3%) | -$141.43M(+76.1%) | -$384.73M(+36.8%) |
| Sep 2018 | - | -$80.33M(-11.3%) | -$281.25M(+39.3%) |
| Jun 2018 | - | -$90.60M(+25.2%) | -$201.89M(+79.5%) |
| Mar 2018 | - | -$72.38M(+90.7%) | -$112.46M(+173.2%) |
| Dec 2017 | -$255.92M(+18.4%) | -$37.94M(+3802.9%) | -$41.17M(+1006.2%) |
| Sep 2017 | - | -$972.20K(-17.0%) | -$3.72M(+30.7%) |
| Jun 2017 | - | -$1.17M(+8.2%) | -$2.85M(+57.7%) |
| Mar 2017 | - | -$1.08M(+118.5%) | -$1.81M(+115.6%) |
| Dec 2016 | -$216.21M(-6579.2%) | - | - |
| Dec 2016 | - | -$495.60K(+401.1%) | -$837.90K(-484.9%) |
| Sep 2016 | - | -$98.90K(-23.5%) | $217.70K(-87.7%) |
| Jun 2016 | - | -$129.20K(+13.1%) | $1.78M(-36.8%) |
| Mar 2016 | - | -$114.20K(-120.4%) | $2.81M(-15.8%) |
| Dec 2015 | $3.34M(-151.5%) | $560.00K(-61.6%) | $3.34M(-61.1%) |
| Sep 2015 | - | $1.46M(+61.4%) | $8.58M(<-9900.0%) |
| Jun 2015 | - | $904.00K(+118.4%) | -$2000.00(-100.1%) |
| Mar 2015 | - | $414.00K(-92.9%) | $3.02M(-146.5%) |
| Dec 2014 | -$6.48M(+312.3%) | $5.80M(-181.5%) | -$6.48M(-54.5%) |
| Sep 2014 | - | -$7.12M(-281.7%) | -$14.24M(+75.9%) |
| Jun 2014 | - | $3.92M(-143.2%) | -$8.10M(-32.7%) |
| Mar 2014 | - | -$9.08M(+362.2%) | -$12.03M(+665.4%) |
| Dec 2013 | -$1.57M(-83.5%) | -$1.96M(+101.2%) | -$1.57M(-57.1%) |
| Sep 2013 | - | -$976.00K(>+9900.0%) | -$3.66M(-17.5%) |
| Jun 2013 | - | -$7000.00(-100.5%) | -$4.43M(+32.5%) |
| Mar 2013 | - | $1.38M(-134.0%) | -$3.35M(-64.9%) |
| Dec 2012 | -$9.55M(-67.6%) | -$4.05M(+131.5%) | -$9.55M(-59.0%) |
| Sep 2012 | - | -$1.75M(-262.0%) | -$23.28M(-10.2%) |
| Jun 2012 | - | $1.08M(-122.4%) | -$25.92M(-15.3%) |
| Mar 2012 | - | -$4.82M(-72.9%) | -$30.58M(+3.9%) |
| Dec 2011 | -$29.42M(+6.0%) | -$17.79M(+305.4%) | -$29.42M(+67.9%) |
| Sep 2011 | - | -$4.39M(+22.4%) | -$17.53M(-18.1%) |
| Jun 2011 | - | -$3.58M(-2.2%) | -$21.41M(-2.4%) |
| Mar 2011 | - | -$3.67M(-37.8%) | -$21.93M(-21.0%) |
| Dec 2010 | -$27.75M(+244.9%) | -$5.89M(-28.8%) | -$27.75M(+22.5%) |
| Sep 2010 | - | -$8.27M(+101.7%) | -$22.65M(+5.9%) |
| Jun 2010 | - | -$4.10M(-56.8%) | -$21.39M(-13.8%) |
| Mar 2010 | - | -$9.49M(+1108.9%) | -$24.82M(+208.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$8.05M(-86.4%) | -$785.00K(-88.8%) | -$8.05M(-58.9%) |
| Sep 2009 | - | -$7.01M(-6.9%) | -$19.56M(-31.7%) |
| Jun 2009 | - | -$7.53M(-203.4%) | -$28.62M(-19.2%) |
| Mar 2009 | - | $7.28M(-159.2%) | -$35.42M(-40.2%) |
| Dec 2008 | -$59.22M(+13.1%) | -$12.30M(-23.5%) | -$59.22M(+0.5%) |
| Sep 2008 | - | -$16.07M(+12.1%) | -$58.93M(-0.6%) |
| Jun 2008 | - | -$14.33M(-13.2%) | -$59.31M(+3.4%) |
| Mar 2008 | - | -$16.52M(+37.5%) | -$57.35M(+9.5%) |
| Dec 2007 | -$52.37M(+94.9%) | -$12.02M(-27.0%) | -$52.37M(+2.7%) |
| Sep 2007 | - | -$16.45M(+33.0%) | -$51.02M(+20.4%) |
| Jun 2007 | - | -$12.37M(+7.2%) | -$42.38M(+38.6%) |
| Mar 2007 | - | -$11.54M(+8.2%) | -$30.57M(+13.7%) |
| Dec 2006 | -$26.88M(-16.4%) | -$10.66M(+36.6%) | -$26.88M(+6.9%) |
| Sep 2006 | - | -$7.81M(+1294.3%) | -$25.13M(-3.8%) |
| Jun 2006 | - | -$560.00K(-92.9%) | -$26.14M(-22.9%) |
| Mar 2006 | - | -$7.85M(-12.0%) | -$33.92M(+5.5%) |
| Dec 2005 | -$32.16M(+12.4%) | -$8.92M(+1.2%) | -$32.16M(+10.3%) |
| Sep 2005 | - | -$8.81M(+5.6%) | -$29.16M(+4.5%) |
| Jun 2005 | - | -$8.34M(+37.1%) | -$27.91M(+3.2%) |
| Mar 2005 | - | -$6.09M(+2.8%) | -$27.05M(-5.4%) |
| Dec 2004 | -$28.61M(+1236.2%) | -$5.92M(-21.7%) | -$28.61M(+0.0%) |
| Sep 2004 | - | -$7.55M(+0.9%) | -$28.61M(+4.8%) |
| Jun 2004 | - | -$7.49M(-2.0%) | -$27.30M(+298.0%) |
| Mar 2004 | - | -$7.64M(+29.2%) | -$6.86M(+220.4%) |
| Dec 2003 | -$2.14M(-84.1%) | -$5.92M(-5.3%) | -$2.14M(+6.0%) |
| Sep 2003 | - | -$6.25M(-148.3%) | -$2.02M(-344.7%) |
| Jun 2003 | - | $12.95M(-542.8%) | $825.00K(-106.1%) |
| Mar 2003 | - | -$2.92M(-49.5%) | -$13.59M(+0.9%) |
| Dec 2002 | -$13.47M(+45.9%) | -$5.79M(+70.1%) | -$13.47M(+25.9%) |
| Sep 2002 | - | -$3.41M(+132.4%) | -$10.70M(+17.4%) |
| Jun 2002 | - | -$1.47M(-47.7%) | -$9.12M(-6.1%) |
| Mar 2002 | - | -$2.80M(-7.4%) | -$9.71M(+5.3%) |
| Dec 2001 | -$9.23M(-4.7%) | -$3.03M(+65.8%) | -$9.23M(+23.5%) |
| Sep 2001 | - | -$1.82M(-11.5%) | -$7.47M(-22.5%) |
| Jun 2001 | - | -$2.06M(-10.9%) | -$9.64M(-1.9%) |
| Mar 2001 | - | -$2.31M(+82.4%) | -$9.83M(+1.5%) |
| Dec 2000 | -$9.69M(+15.4%) | -$1.27M(-68.2%) | -$9.69M(-13.6%) |
| Sep 2000 | - | -$4.00M(+77.4%) | -$11.22M(+23.0%) |
| Jun 2000 | - | -$2.25M(+3.6%) | -$9.13M(+10.3%) |
| Mar 2000 | - | -$2.17M(-22.4%) | -$8.27M(-0.3%) |
| Dec 1999 | -$8.40M(+833.3%) | -$2.80M(+47.4%) | -$8.30M(+23.9%) |
| Sep 1999 | - | -$1.90M(+35.7%) | -$6.70M(+34.0%) |
| Jun 1999 | - | -$1.40M(-36.4%) | -$5.00M(+47.1%) |
| Mar 1999 | - | -$2.20M(+83.3%) | -$3.40M(+240.0%) |
| Dec 1998 | -$900.00K(-80.0%) | -$1.20M(+500.0%) | -$1.00M(-41.2%) |
| Sep 1998 | - | -$200.00K(-200.0%) | -$1.70M(-39.3%) |
| Jun 1998 | - | $200.00K(0.0%) | -$2.80M(-28.2%) |
| Mar 1998 | - | $200.00K(-110.5%) | -$3.90M(-13.3%) |
| Dec 1997 | -$4.50M(+1025.0%) | -$1.90M(+46.2%) | -$4.50M(+73.1%) |
| Sep 1997 | - | -$1.30M(+44.4%) | -$2.60M(+116.7%) |
| Jun 1997 | - | -$900.00K(+125.0%) | -$1.20M(+300.0%) |
| Mar 1997 | - | -$400.00K(-500.0%) | -$300.00K(-400.0%) |
| Dec 1996 | -$400.00K(-500.0%) | - | - |
| Sep 1996 | - | $100.00K(-50.0%) | $100.00K(-150.0%) |
| Jun 1996 | $100.00K(-200.0%) | - | - |
| Mar 1996 | - | $200.00K(-200.0%) | -$200.00K(-50.0%) |
| Dec 1995 | - | -$200.00K(0.0%) | -$400.00K(+300.0%) |
| Jun 1995 | -$100.00K(-150.0%) | -$200.00K(-300.0%) | -$100.00K(-150.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(-33.3%) |
| Jun 1994 | $200.00K | $100.00K(-50.0%) | $300.00K(+50.0%) |
| Sep 1993 | - | $200.00K | $200.00K |
FAQ
- What is Moderna annual net profit?
- What is the all time high annual net income for Moderna?
- What is Moderna annual net income year-on-year change?
- What is Moderna quarterly net profit?
- What is the all time high quarterly net income for Moderna?
- What is Moderna quarterly net income year-on-year change?
- What is Moderna TTM net profit?
- What is the all time high TTM net income for Moderna?
- What is Moderna TTM net income year-on-year change?
What is Moderna annual net profit?
The current annual net income of MRNA is -$3.56B
What is the all time high annual net income for Moderna?
Moderna all-time high annual net profit is $12.20B
What is Moderna annual net income year-on-year change?
Over the past year, MRNA annual net profit has changed by +$1.15B (+24.46%)
What is Moderna quarterly net profit?
The current quarterly net income of MRNA is -$1.12B
What is the all time high quarterly net income for Moderna?
Moderna all-time high quarterly net profit is $4.87B
What is Moderna quarterly net income year-on-year change?
Over the past year, MRNA quarterly net profit has changed by -$1.34B (-616.13%)
What is Moderna TTM net profit?
The current TTM net income of MRNA is -$3.56B
What is the all time high TTM net income for Moderna?
Moderna all-time high TTM net profit is $14.64B
What is Moderna TTM net income year-on-year change?
Over the past year, MRNA TTM net profit has changed by +$1.15B (+24.46%)